Shree Pacetronix (BSE 527005)₹175.25+0.14%Medical Equipment & Supplies
In the Jun 2026 quarter (consolidated), Shree Pacetronix reported sales of ₹4.89 Cr, down 8.1% from Jun 2025, and net profit of ₹0.75 Cr, up 15.4% year on year. For the year to Mar 2026, sales were ₹21.58 Cr and net profit ₹3.13 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.22 | 4.29 | 6.63 | 4.84 | 4.03 | 3.62 | 4.27 | 5.32 | 6.58 | 4.32 | 5.35 | 4.89 |
| Expenses | 4.07 | 3.44 | 4.21 | 4.06 | 3.62 | 3.48 | 3.29 | 4.17 | 4.56 | 3.89 | 3.73 | 3.70 |
| Operating Profit | 1.16 | 0.86 | 2.43 | 0.79 | 0.42 | 0.15 | 0.99 | 1.17 | 2.02 | 0.44 | 1.64 | 1.20 |
| OPM % | 22.0% | 19.8% | 36.4% | 16.1% | 10.2% | 3.9% | 22.9% | 21.8% | 30.5% | 9.9% | 30.4% | 24.3% |
| Other Income | 0.03 | 0.04 | 0.06 | 0.06 | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | 0.03 | 0.06 | 0.04 |
| Interest | 0.12 | 0.09 | 0.10 | 0.13 | 0.17 | 0.16 | 0.14 | 0.13 | 0.09 | 0.12 | 0.07 | 0.04 |
| Depreciation | 0.19 | 0.21 | 0.35 | 0.20 | 0.20 | 0.16 | 0.20 | 0.16 | 0.18 | 0.16 | 0.20 | 0.16 |
| Profit before tax | 0.87 | 0.57 | 2.03 | 0.51 | 0.07 | −0.17 | 0.66 | 0.90 | 1.76 | 0.16 | 1.42 | 1.03 |
| Tax % | 22.0% | 28.5% | 28.7% | 27.9% | 33.3% | −31.3% | 29.1% | 24.7% | 25.1% | 66.6% | 21.2% | 25.4% |
| Net Profit | 0.66 | 0.39 | 1.42 | 0.36 | 0.02 | −0.10 | 0.44 | 0.65 | 1.30 | 0.05 | 1.10 | 0.75 |
| EPS (Rs) | 1.87 | 1.12 | 3.98 | 1.04 | 0.09 | −0.32 | 1.26 | 1.84 | 3.63 | 0.17 | 2.97 | 2.04 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.42 | 6.92 | 6.78 | 7.26 | 8.75 | 7.54 | 9.20 | 20.19 | 21.98 | 16.62 | 21.58 | 21.14 |
| Expenses | 6.35 | 6.37 | 5.86 | 6.47 | 7.54 | 6.59 | 7.43 | 14.76 | 16.10 | 14.30 | 16.34 | 15.88 |
| Operating Profit | 1.08 | 0.56 | 0.93 | 0.79 | 1.21 | 0.95 | 1.79 | 5.47 | 5.90 | 2.35 | 5.25 | 5.30 |
| OPM % | 14.4% | 7.9% | 13.6% | 10.8% | 13.7% | 12.5% | 19.3% | 26.9% | 26.7% | 14.1% | 24.2% | 25.1% |
| Other Income | 0.03 | 0.06 | 0.02 | 0.18 | 0.05 | 0.06 | 0.08 | 0.11 | 0.15 | 0.13 | 0.13 | 0.17 |
| Interest | 0.36 | 0.41 | 0.33 | 0.33 | 0.37 | 0.36 | 0.28 | 0.31 | 0.46 | 0.60 | 0.42 | 0.32 |
| Depreciation | 0.76 | 0.64 | 0.41 | 0.37 | 0.50 | 0.50 | 0.49 | 0.62 | 0.94 | 0.80 | 0.73 | 0.70 |
| Profit before tax | −0.06 | −0.46 | 0.20 | 0.26 | 0.36 | 0.14 | 1.07 | 4.63 | 4.63 | 1.05 | 4.22 | 4.37 |
| Tax % | 59.9% | −26.8% | 31.5% | 44.0% | 31.3% | 61.4% | 26.4% | 29.4% | 27.4% | 27.8% | 25.4% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.08 | −0.31 | 0.12 | 0.13 | 0.23 | 0.04 | 0.77 | 3.25 | 3.35 | 0.74 | 3.13 | 3.20 |
| EPS (Rs) | −0.26 | −0.90 | 0.37 | 0.40 | 0.68 | 0.15 | 2.18 | 9.05 | 9.34 | 2.09 | 8.38 | 8.81 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.61 | 3.61 | 3.61 | 3.61 | 3.61 | 3.61 | 3.61 | 3.61 | 3.61 | 3.62 | 3.61 | 3.77 |
| Reserves | 1.78 | 1.69 | 1.37 | 1.61 | 1.75 | 1.99 | 2.04 | 2.82 | 6.08 | 9.47 | 10.21 | 14.41 |
| Borrowings | 2.77 | 1.97 | 2.70 | 2.93 | 3.91 | 3.32 | 3.20 | 3.04 | 2.18 | 4.31 | 5.09 | 2.68 |
| Other Liabilities | 0.95 | 1.36 | 1.17 | 1.34 | 1.36 | 2.09 | 2.16 | 2.74 | 4.71 | 4.44 | 4.21 | 4.94 |
| Total Liabilities | 9.11 | 8.63 | 8.85 | 9.49 | 10.63 | 11.01 | 11.01 | 12.21 | 16.58 | 21.84 | 23.12 | 25.80 |
| Fixed Assets | 3.12 | 2.56 | 2.01 | 1.87 | 2.39 | 2.46 | 2.68 | 2.55 | 3.11 | 4.25 | 3.86 | 3.80 |
| CWIP | 0.00 | 0.00 | 0.78 | 1.00 | 1.26 | 1.82 | 1.65 | 1.66 | 1.67 | 0.94 | 0.94 | 0.94 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 5.99 | 6.07 | 6.06 | 6.62 | 6.98 | 6.73 | 6.68 | 8.00 | 11.80 | 16.65 | 18.32 | 21.06 |
| Inventories | 3.17 | 2.54 | 2.59 | 2.26 | 2.32 | 2.01 | 1.97 | 1.67 | 2.99 | 5.75 | 7.04 | 4.84 |
| Trade receivables | 1.33 | 1.79 | 2.14 | 2.66 | 3.04 | 3.21 | 3.01 | 3.22 | 4.70 | 4.65 | 6.62 | 10.61 |
| Cash & equivalents | 0.32 | 0.35 | 0.13 | 0.80 | 0.46 | 0.54 | 0.78 | 1.44 | 0.85 | 0.82 | 1.12 | 1.72 |
| Total Assets | 9.11 | 8.63 | 8.85 | 9.49 | 10.63 | 11.01 | 11.01 | 12.21 | 16.58 | 21.84 | 23.12 | 25.80 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.48 | 1.34 | 0.43 | 1.12 | 0.32 | 2.24 | 1.08 | 1.77 | 1.68 | −0.05 | −0.02 | 2.91 |
| Cash from investing activity | −0.48 | −0.19 | −0.87 | −0.51 | −1.00 | −1.01 | −0.54 | −1.20 | −1.40 | −1.68 | −0.03 | −0.79 |
| Cash from financing activity | 0.19 | −1.13 | 0.21 | −0.49 | 0.35 | −1.16 | −0.30 | −0.44 | −1.09 | 1.74 | 0.18 | −1.60 |
| Net cash flow | 0.17 | 0.02 | −0.21 | 0.09 | −0.33 | 0.07 | 0.24 | 0.11 | −0.81 | 0.03 | 0.13 | 0.53 |
| Capex | 0.60 | 0.19 | 0.94 | 0.49 | 1.23 | 1.43 | 0.75 | 0.40 | 1.22 | 1.37 | 0.71 | 1.22 |
| Free cash flow | −0.03 | 1.16 | −0.47 | 0.64 | −0.73 | 1.14 | 0.54 | 1.43 | 0.50 | −1.39 | −0.74 | 1.70 |
| CFO / OP % | 54.1% | 126.1% | 98.1% | 123.1% | 45.1% | 192.1% | 135.1% | 106.1% | 48.1% | 19.1% | 47.1% | 73.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 72 | 89 | 114 | 144 | 154 | 135 | 147 | 129 | 86 | 78 | 146 | 180 |
| Inventory days | 670 | 358 | 242 | 301 | 275 | 216 | 271 | 193 | 156 | 285 | 462 | 274 |
| Days payable | 30 | 33 | 19 | 50 | 37 | 54 | 49 | 18 | 32 | 12 | 57 | 60 |
| Cash conversion cycle | 713 | 416 | 339 | 397 | 393 | 297 | 370 | 305 | 211 | 352 | 552 | 395 |
| Working capital days | 108 | 117 | 112 | 108 | 101 | 44 | 39 | 24 | 64 | 103 | 159 | 181 |
| ROCE % | 3.6% | 4.2% | −0.8% | 6.5% | 5.1% | 8.0% | 5.3% | 14.5% | 46.2% | 34.8% | 9.2% | 23.4% |
For the Jun 2026 quarter, Shree Pacetronix reported sales of ₹4.89 Cr, down 8.1% year on year and net profit of ₹0.75 Cr, up 15.4% year on year. The operating margin was 24.3%.
Shree Pacetronix's sales for the year to Mar 2026 were ₹21.58 Cr; over the last twelve months they were ₹21.14 Cr.
Net profit for the year to Mar 2026 was ₹3.13 Cr, and ₹3.20 Cr over the last twelve months. Earnings per share over the same trailing period were ₹8.81.
Shree Pacetronix reported borrowings of ₹2.68 Cr at Mar 2026, against cash and equivalents of ₹1.72 Cr.
Cash from operations was ₹2.91 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.70 Cr.